- Home
- GTBP vs UPXI Comparison
GTBP vs UPXI Comparison
Compare GTBP & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- UPXI
- Stock Information
- Founded
- GTBP 1965
- UPXI 2018
- Country
- GTBP United States
- UPXI United States
- Employees
- GTBP N/A
- UPXI N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- GTBP Health Care
- UPXI Health Care
- Exchange
- GTBP Nasdaq
- UPXI Nasdaq
- Market Cap
- GTBP 5.6M
- UPXI 4.6M
- IPO Year
- GTBP N/A
- UPXI 2021
- Fundamental
- Price
- GTBP $2.36
- UPXI $2.20
- Analyst Decision
- GTBP Strong Buy
- UPXI
- Analyst Count
- GTBP 1
- UPXI 0
- Target Price
- GTBP $11.00
- UPXI N/A
- AVG Volume (30 Days)
- GTBP 33.2K
- UPXI 13.2K
- Earning Date
- GTBP 05-14-2025
- UPXI 05-07-2025
- Dividend Yield
- GTBP N/A
- UPXI N/A
- EPS Growth
- GTBP N/A
- UPXI N/A
- EPS
- GTBP N/A
- UPXI N/A
- Revenue
- GTBP N/A
- UPXI $18,625,089.00
- Revenue This Year
- GTBP N/A
- UPXI $299.03
- Revenue Next Year
- GTBP N/A
- UPXI N/A
- P/E Ratio
- GTBP N/A
- UPXI N/A
- Revenue Growth
- GTBP N/A
- UPXI 4.75
- 52 Week Low
- GTBP $1.72
- UPXI $2.03
- 52 Week High
- GTBP $10.66
- UPXI $15.91
- Technical
- Relative Strength Index (RSI)
- GTBP 50.10
- UPXI 38.03
- Support Level
- GTBP $2.10
- UPXI $2.03
- Resistance Level
- GTBP $2.45
- UPXI $2.47
- Average True Range (ATR)
- GTBP 0.18
- UPXI 0.14
- MACD
- GTBP -0.01
- UPXI 0.01
- Stochastic Oscillator
- GTBP 56.43
- UPXI 30.09
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.